ficusin has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W; Li, F; Li, X; Ma, Y; Sun, X; Wang, Y; Xu, M; Yu, D; Zhang, Y; Zou, J | 1 |
| Huang, J; Qin, H; Tang, JQ; Xiong, XL; Yan, SQ; Zhang, LL; Zhou, LS | 1 |
2 other study(ies) available for ficusin and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Psoralen Suppresses Lipid Deposition by Alleviating Insulin Resistance and Promoting Autophagy in Oleate-Induced L02 Cells.
Topics: AMP-Activated Protein Kinases; Autophagy; Chloroquine; Ficusin; Humans; Insulin Resistance; Lipid Metabolism; Non-alcoholic Fatty Liver Disease; Oleic Acid | 2022 |
[Psoralen and isopsoralen improve lipid metabolism disorder via inhibition of NF-κB activation in LO2 cells].
Topics: Cell Line; Ficusin; Furocoumarins; Humans; Lipid Metabolism; NF-kappa B; Non-alcoholic Fatty Liver Disease | 2019 |